Brokerages Set Xylem Inc (NYSE:XYL) Target Price at $78.69

Xylem Inc (NYSE:XYL) has received a consensus recommendation of “Buy” from the sixteen brokerages that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $78.69.

XYL has been the topic of several analyst reports. Janney Montgomery Scott raised Xylem from a “neutral” rating to a “buy” rating and set a $86.00 target price on the stock in a research report on Friday, May 3rd. ValuEngine lowered Xylem from a “buy” rating to a “hold” rating in a research report on Tuesday, May 14th. Zacks Investment Research lowered Xylem from a “hold” rating to a “sell” rating in a research report on Friday, April 5th. BMO Capital Markets reissued a “buy” rating and set a $85.00 price target on shares of Xylem in a report on Monday, February 25th. Finally, Stifel Nicolaus lowered their price target on Xylem from $93.00 to $89.00 and set a “buy” rating on the stock in a report on Friday, May 3rd.

In other news, Director Steven R. Loranger sold 10,000 shares of the firm’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $76.99, for a total transaction of $769,900.00. Following the transaction, the director now directly owns 26,744 shares of the company’s stock, valued at $2,059,020.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Claudia S. Toussaint sold 2,344 shares of the firm’s stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $78.53, for a total value of $184,074.32. Following the transaction, the senior vice president now directly owns 43,761 shares in the company, valued at $3,436,551.33. The disclosure for this sale can be found here. Insiders have sold 64,409 shares of company stock worth $5,097,353 over the last three months. Corporate insiders own 0.85% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. boosted its stake in Xylem by 3.6% during the first quarter. BlackRock Inc. now owns 14,986,762 shares of the industrial products company’s stock valued at $1,184,554,000 after buying an additional 516,715 shares in the last quarter. Parnassus Investments CA boosted its stake in Xylem by 0.4% during the first quarter. Parnassus Investments CA now owns 6,274,124 shares of the industrial products company’s stock valued at $495,907,000 after buying an additional 26,743 shares in the last quarter. Impax Asset Management Group plc boosted its stake in Xylem by 18.3% during the fourth quarter. Impax Asset Management Group plc now owns 4,299,123 shares of the industrial products company’s stock valued at $286,837,000 after buying an additional 666,437 shares in the last quarter. Norges Bank bought a new position in Xylem during the fourth quarter valued at about $251,391,000. Finally, Geode Capital Management LLC boosted its stake in Xylem by 6.4% during the first quarter. Geode Capital Management LLC now owns 2,416,687 shares of the industrial products company’s stock valued at $190,670,000 after buying an additional 146,198 shares in the last quarter. 85.44% of the stock is currently owned by institutional investors.

NYSE XYL traded up $0.21 during trading hours on Wednesday, hitting $80.21. The company had a trading volume of 361,350 shares, compared to its average volume of 870,103. Xylem has a fifty-two week low of $60.65 and a fifty-two week high of $84.41. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.02. The firm has a market capitalization of $14.39 billion, a PE ratio of 27.85, a P/E/G ratio of 1.49 and a beta of 1.19.

Xylem (NYSE:XYL) last issued its earnings results on Thursday, May 2nd. The industrial products company reported $0.52 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by ($0.06). Xylem had a return on equity of 19.46% and a net margin of 10.50%. The company had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.25 billion. During the same period in the prior year, the business earned $0.51 earnings per share. Xylem’s quarterly revenue was up 1.6% on a year-over-year basis. Equities research analysts expect that Xylem will post 3.23 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 27th. Stockholders of record on Thursday, May 30th will be issued a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 1.20%. The ex-dividend date is Wednesday, May 29th. Xylem’s dividend payout ratio (DPR) is 33.33%.

About Xylem

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Recommended Story: What Does Beta Mean In Stock Selection

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.